Literature DB >> 18439417

Targeting lipophilic cations to mitochondria.

Michael P Murphy1.   

Abstract

Mitochondrial function and dysfunction contributes to a range of important aspects of biomedical research. Consequently there is considerable interest in developing approaches to modify and report on mitochondria in cells and in vivo. One approach has been to target bioactive molecules to mitochondria by conjugating them to lipophilic cations. Due to the large mitochondrial membrane potential, the cations are accumulated within mitochondria inside cells. This approach had been used to develop mitochondria-targeted antioxidants that selectively block mitochondrial oxidative damage and prevent some types of cell death and also to develop probes of mitochondrial function. Here we outline some of the background to the development of these compounds.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18439417     DOI: 10.1016/j.bbabio.2008.03.029

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  146 in total

1.  A series of carbazole cationic compounds with large two-photon absorption cross sections for imaging mitochondria in living cells with two-photon fluorescence microscopy.

Authors:  Xin Liu; Yuming Sun; Yuanhong Zhang; Ning Zhao; Hongshi Zhao; Guancong Wang; Xiaoqiang Yu; Hong Liu
Journal:  J Fluoresc       Date:  2010-10-16       Impact factor: 2.217

2.  Chemical genetics analysis of an aniline mustard anticancer agent reveals complex I of the electron transport chain as a target.

Authors:  Bogdan I Fedeles; Angela Y Zhu; Kellie S Young; Shawn M Hillier; Kyle D Proffitt; John M Essigmann; Robert G Croy
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

3.  Cell-penetrating and mitochondrion-targeting molecules.

Authors:  George Appiah Kubi; Dehua Pei
Journal:  Methods Enzymol       Date:  2020-06-17       Impact factor: 1.600

4.  Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo.

Authors:  Swati Biswas; Namita S Dodwadkar; Pranali P Deshpande; Vladimir P Torchilin
Journal:  J Control Release       Date:  2012-01-20       Impact factor: 9.776

5.  Synthesis, characterization and efficacy of mitochondrial targeted delivery of TPP-curcumin in rotenone-induced toxicity.

Authors:  Whidul Hasan; Rajesh Kumar Kori; Khilashwar Thakre; Rajesh Singh Yadav; Deepali Jat
Journal:  Daru       Date:  2019-07-01       Impact factor: 3.117

Review 6.  Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities.

Authors:  Ines Batinic-Haberle; Ivan Spasojevic; Hubert M Tse; Artak Tovmasyan; Zrinka Rajic; Daret K St Clair; Zeljko Vujaskovic; Mark W Dewhirst; Jon D Piganelli
Journal:  Amino Acids       Date:  2010-05-16       Impact factor: 3.520

7.  Photothermal and photodynamic activity of polymeric nanoparticles based on α-tocopheryl succinate-RAFT block copolymers conjugated to IR-780.

Authors:  Raquel Palao-Suay; Francisco M Martín-Saavedra; María Rosa Aguilar; Clara Escudero-Duch; Sergio Martín-Saldaña; Francisco J Parra-Ruiz; Nathan A Rohner; Susan N Thomas; Nuria Vilaboa; Julio San Román
Journal:  Acta Biomater       Date:  2017-05-13       Impact factor: 8.947

8.  Multifunctional decoration of alpha-tocopheryl succinate-based NP for cancer treatment: effect of TPP and LTVSPWY peptide.

Authors:  Raquel Palao-Suay; María Rosa Aguilar; Francisco J Parra-Ruiz; Sergio Martín-Saldaña; Nathan A Rohner; Susan N Thomas; Julio San Román
Journal:  J Mater Sci Mater Med       Date:  2017-08-31       Impact factor: 3.896

Review 9.  Review: Mitochondria and disease progression in multiple sclerosis.

Authors:  D Mahad; H Lassmann; D Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2008-12       Impact factor: 8.090

Review 10.  Targeted delivery of radioprotective agents to mitochondria.

Authors:  Irina Zabbarova; Anthony Kanai
Journal:  Mol Interv       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.